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Abstract We have previously described a partial cDNA se-
quence encoding a RhoGAP protein, GAP25 that is homologous
to the recently reported ArhGAP9 and ArhGAP12. We now
describe a related new member ArhGAP15 that shares a number
of domain similarities, including a pleckstrin homology (PH)
domain, a RhoGAP domain and a novel motif N-terminal to
the GAP domain. This novel motif was found to be responsible
for nucleotide-independent Rac1 binding. Using swop mutants of
Rac/Cdc42, we have established that the binding is through the
C-terminal half of Rac1. The GAP domain of ArhGAP15
showed speci¢city towards Rac1 in vitro. The PH domain is
required for ArhGAP15 to localize to cell periphery and over-
expression of the full-length ArhGAP15, but not the mutant
with a partial deletion of the PH domain, resulted in an increase
in actin stress ¢bers and cell contraction. These morphological
e¡ects can be attenuated by the co-expression of dominant neg-
ative Rac1N17. HeLa cells expressing ArhGAP15 were also re-
sistant to phorbol myristatate acetate treatment, suggesting that
ArhGAP15 is a potential regulator of Rac1.
4 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The Rho GTPases such as Cdc42, Rac1 and RhoA regulate
diverse biological processes including actin cytoskeletal dy-
namics, cell adhesion, cell polarity, cell cycle progression
and transcriptional activation in response to external stimuli
[1^3]. In adherent cells such as ¢broblast and HeLa cells,
activation of RhoA causes stress ¢ber and focal adhesion
formations, whereas Rac1 and Cdc42 correspondently induce
lamellipodia and ¢lopdodia respectively [3]. The co-ordinated
interplay of RhoA, Rac1 and Cdc42 is crucial for proper cell
attachment and motility [4]. Like Ras oncoproteins, the Rho
family GTPases cycle between the active GTP-bound form
and the inactive GDP-bound form through intrinsic GTPase
activity. Exchange of GDP for GTP is enhanced by guanine
nucleotide exchange factors, whereas the hydrolysis of GTP-
to GDP-bound form can be catalyzed by a variety of GTPase
activating proteins (GAPs), thereby resulting in down-regula-
tion of the prospective GTPase. A recent genome-wide survey
of human RhoGAP proteins has uncovered at least 53 distinct
gene sequences potentially encoding GAP proteins [5]. Phylo-
genetic analysis of the GAP domain has revealed that these
proteins can be categorized into a distinct family that may be
functionally related. Apart from the RhoGAP domains, these
proteins also contain regulatory regions consisting of diverse
functional modules known to be involved in cytoskeletal reg-
ulation and protein^protein interactions, suggesting that they
may also participate in molecular complexes speci¢c for their
cellular activities.
Here we describe a novel ArhGAP15 with N-terminal
pleckstrin homology (PH) domain and C-terminal GAP do-
main with speci¢c activity towards Rac1. Structurally and
phylogenetically, it is most closely related to ArhGAP9 [6]
and ArhGAP12 [7]. These RhoGAP proteins also share a
common motif that interacts with Rac1. We also show that
both PH and GAP activity towards Rac1 are essential for its
cytoskeletal e¡ects.
2. Materials and methods
2.1. Construction of expression vectors
Full length human ArhGAP15 cDNA was derived from EST clone
R20038. The coding region was obtained by polymerase chain reac-
tion (PCR) using two adapter primers, 5P-CGGGATCCATGCA-
GAAATCTACAAATTC-3P (forward) and 5P-TCCCCCGGGCAT-
CAAGACAGATGTG-3P (reverse). The 1.5 kb PCR fragment was
digested with BamH1 and Sma1 and cloned into pXJ40-FLAG and
pGEX4T1 vectors for sequencing and expression studies. Partial PH
domain deletion mutant (residues 128^475) was obtained by PCR
using 5P-CGGGATCCATGAAAACTGGGCACAAACC-3P as for-
ward primer and the PCR product was similarly subcloned into
pXJ40-FLAG and pGEX4T1 vectors. The GAP domain (residues
263^475) construct was obtained by subcloning an internal Xmn1
fragment into SmaI-digested pGEX4T1 for expression. The Arh-
GAP15-BD (encoding residues 240^332) construct in pGEX4T1 was
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obtained by subcloning a BamH1/HincII fragment from PCR reaction
using oligonucleotide 5P-CAGGATCCAGTGCTTCCGATACAAG-
CG-3P as forward primer. The PH domain construct (encoding resi-
dues 1^262) in pXJ40-FLAG was obtained by ligating the BamH1/
XmnI fragment from the full-length clone to BamH1/Sma1 digested
vector. All PCR subclones were veri¢ed by DNA sequencing.
Rac1, Cdc42, RhoA, Abr GAP domain and KPAK (p21-activated
kinase) p21-binding domain (PAK-BD) in pGEX vectors, and
Rac1N17 in pXJ40-HA vector were obtained as previously described
[8,9]. Swop mutants of Rac1/Cdc42 were obtained by two-rounded
PCR protocol [9]. Rac1 was also subcloned into pGEX4T1-BirA vec-
tor to obtain in vivo biotinylation of the fusion protein in Escherichia
coli (unpublished data).
2.2. Preparation of recombinant proteins, GAP and GTPase-binding
assays
GST-fusion proteins with ArhGAP151475, ArhGAP15263475 (Arh-
GAP15-GAP), ArhGAP15240332 (ArhGAP15-BD), GAP domain of
ABR (active breakpoint cluster region gene product related protein)
and RhoGAP190, KPAK, RhoA, Cdc42, Rac1 and its swop mutants
(Rac164Cdc42, Cdc4264Rac1 and Cdc4264Rac1107Cdc42) were ob-
tained as fusion proteins according to standard protocol. For the
GST-biotinylated Rac1 (containing a biotin acceptor site after the
thrombin cleavage site), the protein was cleaved from GST with
thrombin according to recommended protocol.
For GAP activity measurement, both ¢lter and solution assays were
used as previously described [10]. A ¢lter assay was used for determin-
Fig. 1. ArhGAP15 is a member of related RhoGAP proteins. A: Amino acid sequence of the human ArhGAP15. The N-terminal PH domain
is in bold and boxed and the C-terminal RhoGAP domain is in bold letters. The conserved central motif (see also C) is underlined. B: Com-
parison of PH domain of ArhGAP15 and other PH containing related proteins. The PH domain of human ArhGAP15, ArhGAP9, ArhGAP12,
spectrin (SPPH-1) and spectrin binding protein (SPBP) were aligned with Clustal Method from DNASTAR. Identical amino acid residues are
highlighted in black squares. C: Comparison of a conserved central motif from ArhGAP15 and related GAP proteins. D: Phylogenetic tree of
ArhGAP15 with some RhoGAP proteins. The numbers denote the number of residues that are varied from each other as derived from DNAS-
TAR program. E: Expression of ArhGAP15. Human mRNA blot was purchased from Clontech and total RNA from HL-60 cells (20 Wg)
were separated on 1% agarose-formaldehyde gel and transferred onto Hybond (Amersham) for probing with full-length ArhGAP cDNA labeled
with [32P]dCTP by random priming [12]. Br, brain; sp, spleen; lu, lung; sk, skeletal muscle; ki, kidney; th, thymus. Arrows indicate the posi-
tion of the di¡erent mRNA sizes.
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ing the interaction of ArhGAP15 with various p21 proteins [11].
When biotinylated Rac1 was used, the detection was with strepta-
vidin-HRP and ECL kit (Amersham) and subsequent exposure to
X-ray ¢lm.
2.3. Cell culture, transfection, microinjection, cell staining and
immuno£uorescence microscopy and cell fractionation
HeLa cells were maintained and transfected using lipofectamine as
described [9]. For microinjection of HeLa cells, subcon£uent cells
were plated on coverslips 48 h before being microinjected with the
di¡erent ArhGAP15 constructs (50 ng/Wl). Two to four hours after
injection, cells were ¢xed with 4% paraformaldehyde and stained with
anti-FLAG (M2; IBI)/FITC anti-mouse antibodies alone or double-
stained with TRITC^phalloidin. Stained cells were analyzed with a
Bio-Rad Radiance 2000 Confocal Imager adapted to a Nikon micro-
scope. For phorbol myristatate acetate (PMA) treatment, HeLa cells
were treated with PMA (30 ng/ml) for 30 min before ¢xation and
double staining with anti-FLAG/FITC anti-mouse and TRITC^phal-
loidin. For cell transfections, subcon£uent HeLa or COS-7 cells were
transfected with various constructs in lipofectamine (Life Technolo-
gies, Inc.). Cells were harvested 24 h after transfection and soluble cell
extracts were obtained with lysis bu¡er containing 25 mM HEPES,
pH 7.7, 0.15 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM sodium
vanadate, 20 mM L-glycerol phosphate, 5% glycerol, 0.1% Triton
X-100 and 1U inhibitor mix (Roche Molecular Biochemicals). Immu-
noprecipitations and protein analyses were performed as described
previously [9].
For preparation of soluble and pellet fractions for cellular local-
ization of ArhGAP15, COS-7 cells transfected with the various con-
structs of ArhGAP15 were harvested with lysis bu¡er containing
25 mM Tris^HCl, pH 8.0, 2 mM MgCl2, 2 mM dithiothreitol,
0.25 M sucrose and 0.05% Triton. After removing cell debris by cen-
trifuging at 1000Ug for 10 min, the supernatant was further centri-
fuged at 100 000Ug for 30 min to obtain the soluble (supernatant)
and membrane pellet fractions for further analysis.
3. Results
3.1. ArhGAP15 is a member of related RhoGAP proteins
Using degenerate primers to the conserved nucleotide se-
quence of the RhoGAP cDNAs, we have previously isolated
a number of cDNAs including L-Chimaerins [12] and ABR
[8]. We also detected a short cDNA fragment termed GAP25
[13] that represents a less abundant mRNA in the rat brain,
which bears resemblance to the recently reported human Arh-
GAP9, a multi-domained RhoGAP protein with SH3, PH and
WW domains [6]. More recently, a related ArhGAP12 that
has similar domain arrangement was reported [7] and has
been categorized as phylogenetically related RhoGAP pro-
teins [5]. Two other related RhoGAP proteins that have
similar GAP domain were also detected. The unreported
ArhGAP15 has a related N-terminal PH domain and a
C-terminal GAP domain most similar to ArhGAP9 and Arh-
GAP12 (Fig. 1A^D). A less characterized EST cDNA clone
aa468877 also contains a related GAP domain (Fig. 1C,D),
C
Fig. 2. ArhGAP15 has speci¢c Rac1 GAP activity. A: Filter overlay
assay for GAP activity. Negative control GST and positive controls
of GAP domain of RhoGAP190 (RhoGAP) and ABR together with
various GST-fusion proteins of ArhGAP15 were separated on 10%
polyacrylamide gel and transferred to PVDF ¢lter for Coomassie
blue staining, renaturation and probing for GAP activity with vari-
ous GTPases exchanged with [Q32P]GTP as previously described
[13]. Band with clear area indicates active GTP hydrolysis and GAP
activity. B: Solution GAP assay for ArhGAP15. GAP activity of
ArhGAP15 towards Rac1 was assayed in solution with [Q32P]GTP-
bound Rac1, Cdc42 and RhoA. A comparison was made with the
GAP domain of ABR (for Rac1 and Cdc42) and RhoGAP190
(RhoA) as controls.
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although the PH domain is not typical (data not shown).
ArhGAP9, ArhGAP12, ArhGAP15 and ESTaa468877 can
therefore be considered as structurally related RhoGAP pro-
teins, with various regulatory domains at their N-termini (Fig.
1D). Most strikingly, these RhoGAP proteins share sequence
homology immediately N-terminal to the GAP domains (Fig.
1C), the function of which has not been previously studied.
Expression of a 1.7 kb mRNA of ArhGAP15 was detected
in human spleen, lung, liver and lymphoid cells such as HL-60
(Fig. 1E). Additional mRNA of di¡erent sizes were also de-
tected in skeletal muscle (1.4 kb) and thymus (3 kb).
3.2. ArhGAP15 has speci¢c GAP activity to Rac1
It has now been established that many of these RhoGAPs
have characteristic activities towards speci¢c GTPases [5,13].
All Chimaerin members are more active towards Rac1, where-
as the related BCR and ABR proteins are active towards both
Rac1 and Cdc42 [8,12]. As the RacGAP members are phylo-
genetically closer to abr and bcr proteins (Fig. 1D), it is of
interest to determine the substrate speci¢city of ArhGAP15.
When ArhGAP15 was expressed as full-length or GAP do-
main GST-fusion proteins, they showed GAP activities to-
wards Rac1, but not Cdc42 and RhoA in both the ¢lter assay
(Fig. 2A) and solution assay (Fig. 2B). They therefore behave
more like the Chimaerin proteins in term of substrate speci-
¢city towards Rac1, although they are structurally more re-
lated to ABR/BCR proteins. However, a recent report has
shown that the related ArhGAP9 has GAP activity toward
both Rac-1 and Cdc42. It should be noted that ArhGAP9 has
an extended loop (residues 576^594; [6]) between the GAP
homology 1 and GAP homology 2 regions. Whether this extra
loop region a¡ects substrate speci¢city remains to be deter-
mined.
3.3. A conserved motif responsible for Rac1 binding
Apart from having RacGAP activities, an apparent obser-
vation was an additional GTPase binding property of Arh-
GAP15 on the ¢lter assay (Fig. 3A). ArhGAP15 containing
the central conserved motif N-terminal to the GAP domain is
required for interaction with Rac1 but not with Cdc42 (Fig.
3A). The weak interaction of the GAP domain alone was not
detectable with this assay (Fig. 3A). We have mapped the BD
of ArhGAP15 to the conserved domain since the expression of
this motif alone is equally e¡ective in binding to Rac1 (Fig.
3B).
To characterize the nature of the interaction, we have used
the swop mutants of Rac1/Cdc42 for the binding experiments.
Here we showed that Rac-1 binding to ArhGAP15 requires
the C-terminal half of Rac1 (Fig. 3C). Furthermore, binding
of ArhGAP15 to mutant Cdc4264Rac1107Cdc42 showed much
weaker binding, suggesting a large part of the C-terminus may
be involved in interaction (Fig. 3C). To see if the interaction
was nucleotide-dependent, as has been documented for CRIB
domain proteins such as that of KPAK, we tested the binding
with GTP-bound and GDP-bound forms of Rac1. As shown
in Fig. 3D, ArhGAP15 interacted equally well with both
GTP- and GDP-bound forms of Rac-1, suggesting that the
GTPase binding is not dependent on the nucleotide state of
Rac-1. Similar Rac-1 binding was also obtained with the re-
lated ArhGAP12 (data not shown) indicating that this binding
property is shared amongst these members of GAP proteins.
Rac-1, but not Cdc42, was also able to interact with Arh-
GAP15 over-expressed in COS-7 cells (Fig. 3E).
3.4. PH domain is required for ArhGAP15 localization to
cell periphery
Both full-length ArhGAP15 and PH domain proteins were
detected in both cytosolic and membrane fractions (Fig. 4A,
top panel), whereas the N-terminal deleted ArhGAP15 pro-
tein (residues 128^475) was predominantly cytosolic. In HeLa
cells expressing full-length ArhGAP15, punctate structure at
the cell periphery was observed (Fig. 4A, lower panel). The
expression of the mutant ArhGAP15 (ArhGAP15128475) with
partial deletion of PH domain showed more di¡used distribu-
tion in cytoplasm (Fig. 4A, b). This distribution of Arh-
GAP15 to the cell periphery is dependent on the PH domain
as the expression of this domain alone clearly showed typical
cell peripheral staining (Fig. 4A, c).
3.5. ArhGAP15 e¡ects on cellular morphology depend on both
PH and GAP domain
Overexpression of ArhGAP15 in HeLa cells by transfection
and prolonged expression generally resulted in cell rounding
(data not shown). To minimize this e¡ect, we microinjected
ArhGAP15 constructs into HeLa cells and observed morpho-
logical e¡ects 2 h after injection. As shown in Fig. 4B, expres-
sion of ArhGAP15 caused rapid cell contraction and a mod-
erate increase in actin stress ¢bers (a and b). These e¡ects
were not observed with the PH domain truncated mutant (c
and d), indicating that an intact PH domain is required not
only for localization of ArhGAP15, but also morphological
consequences. Expression of the PH domain alone was not
su⁄cient to give similar e¡ects (data not shown), suggesting
that both the PH and the C-terminal including the BD and
GAP domain are required for ArhGAP15 biological activities.
These e¡ects of ArhGAP15 can be abrogated when Arh-
C
Fig. 3. ArhGAP conserved central motif binds the C-terminus of Rac1. A: Filter binding assay was carried out with [Q32P]GTP-bound Rac1 ac-
cording to Manser et al. [11]. Fusion proteins of GST, KPAK-BD, and various ArhGAP15 proteins were separated on 10% PAGE. After trans-
ferring to PVDF and renatured with renaturation bu¡er, the ¢lter was incubated with radiolabelled Rac1 for 10 min at 25‡C. After extensive
washing, the ¢lter was exposed to X-ray ¢lm for 2 h at 380‡C. B: Mapping of the Rac1 binding to the conserved central motif. Various dele-
tion mutants were produced as GST-fusion proteins for Rac1 binding as described in A. The minimal construct containing the conserved cen-
tral motif showed intense binding indicating this motif is responsible for Rac1 interaction. C: ArhGAP15 binding requires the C-terminus of
Rac1. Swop mutants of Rac1 and Cdc42 (Cdc4264Rac1, Cdc4264Rac1107Cdc42 and Rac164Cdc42) were used for analysis of region on Rac1
that interact with ArhGAP15. D: Binding of ArhGAP15 to Rac1 is nucleotide independent. Biotinylated Rac1 exchanged with either GDP or
the non-hydrolyzable GTP-QS was used for ¢lter binding assay to ArhGAP15. E: ArhGAP15 expressed in Cos-7 cells interacted with Rac1.
FLAG-tagged ArhGAP15 construct was co-transfected with either HA-tagged Rac1 or Cdc42 construct. Immunoprecipitation (IP) of Arh-
GAG15 was carried out with anti-FLAG antibody and Western blot (WB) analysis was carried out with either anti-FLAG (for ArhGAP15) or
anti-HA antibodies (for Rac1 and Cdc42) on immunoprecipitates (top two panels) and cell lysates (bottom panel).
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AB
Fig. 4. The membrane targeting PH domain and RacGAP domain are both essential for the morphological e¡ects of ArhGAP15. A: Mem-
brane localization of ArhGAP15 is dependent on PH domain. COS-7 cells (top panel) or HeLa cells (lower panel) were transfected with (a)
pXJ40-FLAG ArhGAP151475, (b) pXJ40-FLAG ArhGAP15128475 (GAP domain) or (c) pXJ-FLAG ArhGAP1579262 (PH domain). For COS-
7 cells, soluble and pellet fractions were isolated and 25 Wg of each was separated on a 12% polyacrylamide gel and immunoblotted with mouse
anti-FLAG antibody. For transfected HeLa cells, cells were ¢xed with 4% paraformaldehyde and immunostained with mouse anti-FLAG/
FITC-rabbit anti-mouse antibodies. Bar= 10 WM. B: Cell morphological changes with ArhGAP15 expression depend on both PH and GAP do-
main. HeLa cells were microinjected with either pXJ40-FLAG ArhGAP151475 (a and b), or pXJ40-FLAG ArhGAP15128475 (c and d). In e
and f, cells were co-injected with full-length ArhGAP15 and pXJ40-HA Rac1N17. In g and h, cells microinjected with full-length ArhGAP15
were serum starved and treated with 30 ng/ml PMA for 30 min. Cells were ¢xed with 4% paraformaldehyde and co-stained with mouse anti-
FLAG/FITC anti-mouse and TRITC-conjugated phalloidin. Bar= 10 WM.
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GAP15 was co-expressed with the dominant negative Rac1N17
(Fig. 4B, e and f), suggesting that recycling of Rac1 may be
essential for the morphological phenotype.
Cells showing the morphological e¡ects by the over-expres-
sion of ArhGAP15 were also resistant to Rac1 activation
induced by PMA treatment (Fig. 4B, g and h). This further
supports the notion that ArhGAP15 may be an essential reg-
ulator of Rac1.
4. Discussion
Here we have identi¢ed ArhGAP15 as a closely related
member of a phylogenetically related RhoGAP subfamily
that includes ArhGAP9, ArhGAP12 and an uncharacterized
RhoGAP encoded by an EST cDNA aa468877. ArhGAP15
has a PH domain, which is also common to ArhGAP9 and
ArhGAP12. In addition ArhGAP9 and ARhGAP12 have
SH3 and WW domains in their regulatory N-terminus [5^7].
Most strikingly, all four members have a conserved central
motif N-terminal to the GAP domain that is unique to this
family of GAP proteins. Biochemically we have detected a
speci¢c interaction of this motif with Rac1. This interaction
requires the C-terminus of Rac-1. This is di¡erent from the
known CRIB motif binding which primarily involves the
N-terminal e¡ector loop (N-terminal residues 30^40) of
Rac1/Cdc42 for interaction with a variety of regulatory e¡ec-
tors [14]. Furthermore unlike the CRIB motif, the binding is
nucleotide independent as both GTP- and GDP-bound forms
of Rac1 can interact equally well with ArhGAP15. The sig-
ni¢cance of this binding is currently not known. A similar
binding of Arabidopsis Rop1 GTPase through a central
CRIB motif has been reported for the unique plant RopGAP
proteins [15], where the GTPase binding resulted in an en-
hancement of the GAP activity. It is therefore possible that
for ArhGAP15, the binding to Rac1 may also a¡ect GAP
activity, resulting in an increase in GTP hydrolysis, thereby
down-regulating Rac1. In this respect, it is interesting to know
that ArhGAP15 has a GAP activity towards Rac1, but not
Cdc42 and RhoA.
In general, RhoGAP proteins function in down-regulation
of speci¢c GTPase signals, although some e¡ector functions
have been assigned to some known GAPs. For example, the
expression of n-Chimaerin, a RacGAP protein, gave rise to
multiple rounds of lamellipodia and membrane protrusions,
suggesting that an intact GTPase cycle is required locally for
the cytoskeletal reorganization to occur [16]. Some of these
spatial requirements for e¡ector functions most likely depend
on their distinctive regulatory domains for the various cellular
GAP proteins. In the case of ArhGAP15, over-expression in
general resulted in cell retraction and subsequent cell round-
ing. Within a short period of expression after microinjection,
a gradual cell contraction with concomitant increases in actin
stress ¢bers was observed. The PH domain, which is required
for cell periphery distribution of ArhGAP15, is also essential
for the morphological e¡ects as deletion of the ¢rst 127 amino
acid residues abolished these e¡ects. The PH domain alone is
su⁄cient for cellular localization, but is not e¡ective in pro-
ducing similar cellular e¡ects, indicating that both the PH and
GAP domains are necessary for such cytoskeletal changes.
Cells showing this cytoskeletal arrangement are also resistant
to PMA treatment, which in general, activates Rac1 [17]. It is
not known if this is due to the involvement of both the cell
contraction event, which counteracts the induction of lamelli-
podial formation and/or the direct result of down-regulation
of Rac1. As resistance to PMA treatment was also observed
with the GAP domain of ArhGAP15 alone (data not shown),
down-regulation of Rac1 may play a more important role for
the resulting phenotypic e¡ects observed with the full-length
protein upon PMA treatment. Taken together, these results
suggest that ArhGAP15 could be a genuine regulator of Rac1
signaling.
The N-terminus of ArhGAP15 is also a good in vitro sub-
strate for a number of Rac1 e¡ector kinases including KPAK
and MRCKK (data not shown). It is currently not known
what are the biological consequences of these phosphorylation
events. Phosphorylation of the regulatory domain of Rho-
GAP190 by Src is required for regulating the RhoGAP activ-
ity [18]. Future experiments should address the in vivo mod-
i¢cations and the physiological roles of these structurally and
phylogenetically related RhoGAP proteins.
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